Customer Center
Login | Register

Investor Relations

Investor Relations

Upcoming Event
More events are coming soon.

Stock Information

More >>

Recent News

More >>
Date Title  
Toggle Summary Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners
- Luminex begins rollout of next generation of xMAP® Technology, the gold standard for multiplexing of biological tests   - New xMAP® INTELLIFLEX System enables its Life Science Research Partners and customers to explore new applications, including offering a unique ability to simultaneously detect
Toggle Summary Luminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody Test
- Assay uses multiplexing for highly specific and sensitive detection of IgG antibodies against SARS-CoV-2   - Assay runs on all xMAP® platforms, the gold standard for multiplex serological testing, and detects previous infection and potential immunity to SARS-CoV-2   - Company plans to launch